Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster lunch

1752 - Clinicopathologic Correlation of MACC1 and Sp1 Expression in Lung Adenocarcinoma (558P)

Date

18 Nov 2017

Session

Poster lunch

Presenters

Woo Jung Sung

Citation

Annals of Oncology (2017) 28 (suppl_10): x173-x176. 10.1093/annonc/mdx679

Authors

W.J. Sung, J.Y. Park, K. Park

Author affiliations

  • Pathology, Catholic University of Daegu, School of Medicine, 42472 - Daegu/KR
More

Resources

Abstract 1752

Background

Lung cancer is one of the most common malignant tumor and the leading cause of cancer mortality worldwide. Metastasis-associated with colon cancer-1 (MACC1) is a key regulator of hepatocyte growth factor/c-Met signaling. It was reported that Sp1 is able to interact with MACC1 to regulate the transcriptional activity of the Met promoter. The aim of this study is to investigate the expression and clinicopathologic significance of MACC1 and Sp1 expression and evaluate their biology in lung adenocarcinoma.

Methods

A total 93 cases of tissue microarray from surgical resection for primary lung adenocarcinoma were used. Clinical and pathologic reports were reviewed for age, sex, tumor size, histological grade, T stage, nodal status, distant metastasis, TNM stage, pleural invasion, lymphovascular invasion and survival outcome. Immunohistochemistry for MACC-1 and Sp1 was performed.

Results

MACC1 overexpression was significantly correlated with lymph nodal status (p = 0.026), pleural invasion (p = 0.030) and survival outcome (p = 0.006). High expression of Sp showed statistical significance with T stage (p = 0.017), TNM stage (p = 0.032), disease progression (p = 0.012) and survival outcome (p = 0.0236). Survival analyses revealed that MACC1 (p = 0.012) and SP1 expression (p = 0.023) were associated with worse overall survival. We found correlations between MACC1 and SP1 expression (p = 0.001). High MACC1 expression was an independent prognostic factor for overall survival (p = 0.041) and SP1 was an independent prognostic factor for progression free survival (p = 0.003).

Conclusions

Our study suggests that high MACC1 and Sp1 expression can be used useful marker to predict worse disease progress and survival outcome of lung adenocarcinoma. Additional study about the mechanism sequence of c-MET expression regulated by Sp1 and MACC1 is required.

Clinical trial identification

Legal entity responsible for the study

individual person

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.